Sandor Batkai

Background

About Sandor Batkai

Medical Director | Drug Development Expert | Life Science StrategistI am passionate about translating cutting-edge science into transformative therapies. With deep expertise in RNA-based drug development in the cardiovascular and metabolic field, I have spent my career guiding biotech innovations from early-stage discovery to clinical impact.I keep helping biotech companies navigate the complexities of drug development, scientific strategy, and portfolio growth—turning breakthrough science into real-world success.At Resalis Therapeutics, my clinical and scientific insights are critical in advancing the development of our lead candidate, RES-010. As Co-founder of Cardior Pharmaceuticals, I played pivotal role in the development of a miRNA inhibitor for heart failure, contributing to the company’s successful acquisition by Novo Nordisk in 2024. My Expertise: Leading scientific strategy in biotech and drug development Advising on R&D roadmaps, clinical translation, and competitive landscape Coaching teams on RNA/ASO therapeutics, biotechnology strategy, and innovationI believe that the most impactful biotech breakthroughs happen when science, strategy, and leadership align. If you’re looking for a trusted expert to help shape the future of your innovation, let’s connect.